Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population

Osteopontin Expression in Cardiomyocytes Induces Dilated Cardiomyopathy

(2010) Marie-Ange Renault et al.   Circulation-Heart Failure

The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis

(2010) Chia-Chu Liu et al.   CLINICA CHIMICA ACTA

Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis

(2010) H. von Bibra et al.   DIABETOLOGIA

Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension—Results from the EUTOPIA trial

(2009) Johan M. Lorenzen et al.   ATHEROSCLEROSIS

Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients

(2009) Renato Marciano et al.   CLINICAL IMMUNOLOGY

Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin–angiotensin system in hypertensive rats

(2009) Shigefumi Fukui et al.   HYPERTENSION RESEARCH

Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MI

(2009) Mahipal Singh et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Angiotensin II-Induced Osteopontin Expression in Vascular Smooth Muscle Cells Involves Gq/11, Ras, ERK, Src and Ets-1

(2008) Keiko ABE et al.   HYPERTENSION RESEARCH

Osteopontin Promoter Polymorphism Is Associated With Increased Carotid Intima-Media Thickness

(2008) Lisa de las Fuentes et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY